How common is iron deficiency in women? It depends entirely on the cutoff you use

There is no single answer to how common iron deficiency is in women, because the prevalence depends almost entirely on where you draw the line. In one study of 62,685 women, the same population yielded an iron-deficiency prevalence of 3.12%, 7.43% or 15.33% depending on which of three accepted definitions was applied [s1]. That is the first thing to understand about a number that gets quoted as if it were fixed.

Why the number moves so much

The study drew on the Hemochromatosis and Iron Overload Screening cohort, a multiethnic primary-care screening of women aged 25 and over across five North American centres [s1]. The researchers applied three definitions of iron deficiency to the same women: a strict combined definition (transferrin saturation below 10% and serum ferritin below 15 ng/mL); the World Health Organization threshold of ferritin below 15 ng/mL; and a higher threshold of ferritin below 25 ng/mL, the point at which the body's iron stores start to constrain red-blood-cell production [s1].

Those definitions produced prevalences of 3.12% (1,957 women), 7.43% (4,659 women) and 15.33% (9,611 women) respectively [s1]. Ferritin is the pivot: it is the blood marker of stored iron, and moving its cutoff from 15 to 25 ng/mL roughly doubled the count. This is why one source can call iron deficiency uncommon and another call it widespread while both cite real data — they are using different thresholds, and neither is simply wrong.

Where menstruating women fit

Prevalence was higher in the reproductive-age band. Among 40,381 women aged 25 to 54, the three definitions gave 4.46%, 10.57% and 21.23% [s1]. Among 2,039 women aged 25 to 44 who reported a pregnancy, the figures were higher still: 5.44%, 18.05% and 36.10% [s1]. Menstrual blood loss and pregnancy are the recognised reasons iron deficiency clusters in this age range, and the study's gradient is consistent with that. Under the most inclusive definition, iron-deficient iron stores were present in around one in five reproductive-age women [s1].

The practical implication is not that every menstruating woman is deficient, but that whether she is counted as deficient can hinge on which threshold her clinician's lab uses — and that a "normal" ferritin at one cutoff can be a depleted store at another.

On treatment, the schedule matters

The instinct with iron deficiency is to take iron daily, but a well-conducted trial complicates that. Researchers randomised 150 iron-depleted women (serum ferritin at or below 30 μg/L) to a daily 100-mg iron dose or to the same total amount of iron taken on alternate days [s2]. At equal total doses, the two schedules produced essentially identical iron stores — median serum ferritin of 43.8 versus 44.8 μg/L (P=0.98) [s2].

The difference was in tolerability and, at the margin, in deficiency correction. Gastrointestinal side effects on days of iron intake were significantly more frequent with consecutive daily dosing (a 1.56-fold higher rate; 95% CI 1.38 to 1.77; P<0.0001) [s2]. And by six months, the proportion still iron-deficient was 11.4% with consecutive dosing versus 3.0% with alternate-day dosing (P=0.049) [s2]. The mechanism the researchers point to is hepcidin, the hormone that throttles iron absorption after a dose — median hepcidin was lower in the alternate-day group (1.9 versus 3.0 nM; P<0.0001), consistent with better fractional absorption when doses are spaced out [s2].

This does not translate into a self-treatment instruction. It is a finding about how absorption physiology interacts with dosing schedule, and iron supplementation — dose, form, duration, and whether it is warranted at all — is a clinical decision. Taking iron without a confirmed deficiency carries its own risks, and the underlying cause of a deficiency, from heavy periods to gastrointestinal bleeding, is what actually needs identifying.

The liftable summary: iron deficiency in women is common but its measured prevalence swings two- to fivefold with the chosen ferritin cutoff, it concentrates in reproductive-age women, and when iron is prescribed, alternate-day dosing was better tolerated than daily in a randomised trial.

This article is informational and is not medical advice. Testing for and treating iron deficiency should be done with a clinician.